Streetbeat News

Products Services

AMZN

ATVI

SQNX

Activision Blizzard Inc (ATVI) has announced that Lara Croft from Tomb Raider will be featured in Call of Duty. This follows the inclusion of other characters and crossovers with artists. The announcement was made on X, formerly known as Twitter. Specific details are not yet disclosed, but players will likely need to purchase a Call of Duty bundle to play as Lara Croft. After Square Enix (SQNX) sold Crystal Dynamics and the Tomb Raider license last year, the future of the series was uncertain. In December, Crystal Dynamics and Amazon.com, Inc.'s (AMZN) Amazon Games revealed its collaboration on a new Tomb Raider game.

Portfolio Pulse from Franca Quarneti

August 24, 2023 | 9:35 pm

UTRS

Minerva Surgical has received a notice of allowance for its U.S. patent application 17/862,657 titled 'Methods And Systems For Endometrial Ablation Utilizing Radio Frequency'.

Portfolio Pulse from Happy Mohamed

August 24, 2023 | 9:21 pm

PONGF

Atari SA (OTC:PONGF) has launched a new replica of their classic Atari 2600 console, the Atari 2600+, available for pre-order at $129.99. The console is compatible with both original and recently released cartridges and comes with a 10-in-1 game cartridge. Atari has also released new cartridge games for purchase. The current Atari company, distinct from the original, has faced financial challenges, including the failure of the 2021 Atari VCS microconsole.

Portfolio Pulse from Franca Quarneti

August 24, 2023 | 8:55 pm

TVTX

Travere Therapeutics is set to present clinical data from the Phase 1/2 COMPOSE study of Pegtibatinase at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2023.

Portfolio Pulse from Benzinga Newsdesk

August 24, 2023 | 8:40 pm

MOG

TXT

Moog Inc. (NYSE:MOG) has been contracted by Bell Textron Inc., a Textron company, to supply flight control content for the U.S. Army's Future Long Range Assault Aircraft (FLRAA), the Bell V-280 Valor. The contract covers core design and development activities through the Middle Tier Acquisition (MTA) phase of the program. Financial terms were not disclosed.

Portfolio Pulse from Happy Mohamed

August 24, 2023 | 8:40 pm

FMC

FMC Corporation (NYSE:FMC) has announced Dodhylex active as the global brand name for its new herbicide, tetflupyrolimet. The herbicide, effective on challenging grass weeds in rice, is expected to be launched in 2025. Dodhylex active is the first active ingredient in the HRAC/WSSA Group 28 and the first new herbicide with a novel mode of action in the industry in over three decades. FMC is also testing Dodhylex active in other crops, including sugarcane, wheat, soybean and corn.

Portfolio Pulse from Happy Mohamed

August 24, 2023 | 8:33 pm

MYO

Myomo, Inc. (NYSE:MYO), a wearable medical robotics company, has received payments for two claims submitted for MyoPro® arm braces provided to Medicare fee-for-service beneficiaries. The company recently delivered the custom-fabricated MyoPro braces to these two patients. The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that includes orthoses/braces such as the MyoPro. If the proposed rule is finalized, MyoPro braces provided to Medicare Part B beneficiaries will be paid on a lump sum basis.

Portfolio Pulse from Happy Mohamed

August 24, 2023 | 8:24 pm

BTCUSD

FOX

FOXA

RUM

The first 2024 Republican primary debate was held and aired on Fox News, a unit of Fox Corporation (NASDAQ:FOX)(NASDAQ:FOXA), and livestreamed on Rumble Inc (NASDAQ:RUM). Despite not attending, former President Donald Trump was a frequently discussed topic. The debate did not cover cryptocurrency, despite interest from voters. Fox and Rumble have rights to the second debate set for Sept. 27.

Portfolio Pulse from Chris Katje

August 24, 2023 | 8:23 pm

BBIO

BridgeBio Pharma, Inc. (NASDAQ:BBIO) announced that detailed Phase 3 results from its study of acoramidis in transthyretin amyloid cardiomyopathy will be presented at the European Society of Cardiology Congress 2023. The company will also host an investor call to discuss the results. In addition, BridgeBio will present a poster on the observed near-complete TTR stabilization of acoramidis in patients with variant transthyretin amyloidosis.

Portfolio Pulse from Happy Mohamed

August 24, 2023 | 8:19 pm

IMNN

IMUNON has entered into a Cooperative Research and Development Agreement (CRADA) for preclinical studies of its PlaCCine modality in preventive vaccines against the Lassa virus. The CRADA will evaluate the immunogenicity and efficacy of two DNA-based Lassa virus vaccine candidates in animal models.

Portfolio Pulse from Benzinga Newsdesk

August 24, 2023 | 8:13 pm